ARTICLE | Clinical News
Oncolym: Began Phase I study
September 25, 2000 7:00 AM UTC
Techniclone Corp. (TCLN), Tustin, Calif. Product: Oncolym Business: Cancer Therapeutic category: Antibody, Cytotoxic Target: HLA-dr on B cells Description: Radiolabeled murine Lym-1 monoclonal antibo...